Ceribell, Inc. (CBLL)

Insider Trading Filed: 2026-05-07

Key Insights

CEO Xingjuan Chao executed a structured 10b5-1 trading plan on 05/05/2026, selling 38,554 shares across multiple transactions at prices ranging from $19.77 to $20.48, generating approximately $776,000 in proceeds.
Following the sales, Chao maintains direct beneficial ownership of 836,347 common shares plus 369,088 shares indirectly held through the ACP 2021 Trust, indicating substantial retained equity stake in the company.
The insider exercised 25,000 stock options (1,446 + 23,554 vesting options) at $4.70 per share before immediately selling approximately 38,554 shares at ~$20.12, representing a significant gain realization while maintaining significant ownership.
The Form 4 filing shows controlled, pre-planned sales under Rule 10b5-1, suggesting confidence in the stock price at execution rather than distress selling, though the timing and volume warrant monitoring for any changes in management's outlook.

Insider Trading Filed: 2026-04-03

Key Insights

Xingjuan (Jane) Chao, the President and CEO of Ceribell, Inc. (CBLL), has acquired 97,555 shares of the company's common stock through a grant of restricted stock units (RSUs).
Chao also holds an indirect beneficial ownership of 369,088 shares of Ceribell's common stock through the ACP 2021 Trust, of which she is a co-trustee.
Chao has also been granted a stock option to purchase 162,592 shares of Ceribell's common stock, with the shares vesting on a quarterly basis over the next 10 years.

Insider Trading Filed: 2026-04-03

Key Insights

The reporting person, Scott Blumberg, has been granted 30,736 restricted stock units (RSUs) and 51,227 stock options, indicating an increase in his equity ownership in the company.
The stock options have a 10-year term and will vest quarterly over the next 10 years, aligning the reporting person's interests with long-term shareholder value creation.
The reporting person is the Chief Financial Officer of Ceribell, Inc., suggesting continuity and stability in the company's financial leadership.

Insider Trading Filed: 2026-04-03

Key Insights

The reporting person, David Foehr, was granted 22,050 restricted stock units (RSUs) on April 1, 2026, indicating a potential increase in his equity ownership in the company.
Foehr was also granted 36,750 stock options with a strike price of $18.50 and a vesting schedule over 10 years, aligning his incentives with long-term shareholder value creation.
The relatively large amount of RSUs and options granted to a senior finance executive suggests the company's board has confidence in Foehr's leadership and the future prospects of the business.

Insider Trading Filed: 2026-04-03

Key Insights

Joseph S. Manni, the Chief Revenue Officer of Ceribell, Inc. (CBLL), has acquired 30,736 shares of the company's common stock through a restricted stock unit (RSU) grant.
Manni has also been granted a stock option to purchase an additional 51,227 shares of Ceribell's common stock, with a vesting schedule that aligns with the company's long-term growth strategy.
The insider transactions suggest that Manni is confident in Ceribell's future prospects and is aligning his financial interests with those of the company and its shareholders.

Insider Trading Filed: 2026-04-03

Key Insights

The Chief Technology Officer, Raymond Woo, has exercised multiple stock options and sold shares of Ceribell, Inc. (CBLL) on April 1, 2026, indicating his confidence in the company's performance.
Woo acquired 30,736 additional restricted stock units (RSUs), further aligning his interests with those of the company and its shareholders.
The significant amount of shares traded, totaling over 11,000, suggests Woo is actively managing his position in the company.

Insider Trading Filed: 2026-03-27

Key Insights

The reporting person, Xingjuan (Jane) Chao, who is the President and CEO of Ceribell, Inc., has exercised stock options to acquire a total of 55,628 shares of the company's common stock.
Chao now holds a total of 766,792 shares of Ceribell's common stock directly, and has an additional 369,088 shares held indirectly through the ACP 2021 Trust, of which she is a co-trustee.
The timing and amounts of the option exercises suggest continued confidence and alignment of Chao's interests with those of the company and its shareholders.

Insider Trading Filed: 2026-03-05

Key Insights

The reporting person, David Foehr, appears to have exercised stock options and immediately sold a portion of the acquired shares at a significant profit, suggesting potential insider trading activity.
The transactions were executed pursuant to a pre-arranged 10b5-1 trading plan, which may indicate a planned, systematic approach to selling the company's shares.
The magnitude of the transactions, with over 4,500 shares being sold, suggests Foehr may hold a substantial equity position in Ceribell, Inc. and is actively managing his holdings.

Insider Trading Filed: 2026-03-05

Key Insights

The reporting person, Rebecca B. Robertson, is a director of Ceribell, Inc. (CBLL) and has sold 827 shares of the company's common stock for $17.80 per share.
The sale was made pursuant to a Rule 10b5-1 trading plan, indicating a pre-planned transaction that was not necessarily a reaction to current events.
The reporting person still holds 18,749 shares of the company's common stock, representing a significant ownership stake.

Insider Trading Filed: 2026-03-05

Key Insights

Xingjuan Chao, the President and CEO of Ceribell, Inc., has exercised stock options to acquire 25,000 shares of the company's common stock.
Chao has also sold 39,000 shares of Ceribell common stock, likely for personal financial reasons, at an average price of $17.45 per share.
Chao continues to hold a significant stake in the company, with 711,164 shares owned directly and an additional 369,088 shares held indirectly through the ACP 2021 Trust.

Insider Trading Filed: 2026-03-04

Key Insights

The reporting person, Raymond Woo, who is the Chief Technology Officer, executed multiple stock option exercises and sales on March 2, 2026 pursuant to a Rule 10b5-1 trading plan.
The reported transactions indicate that the reporting person exercised stock options with exercise prices of $2.24, $4.70, and $4.70, and then immediately sold the underlying shares at a weighted average price of around $18.25-$18.26.
The reporting person continues to directly own 166,912 shares of the issuer's common stock following these transactions.

Insider Trading Filed: 2026-02-25

Key Insights

The reporting person, Xingjuan Chao, who is the President and CEO of Ceribell, Inc., sold 2,084 shares of the company's common stock to cover tax withholding obligations related to the vesting of restricted stock units.
Chao still beneficially owns a significant number of shares, both directly (725,164 shares) and indirectly through the ACP 2021 Trust (369,088 shares), indicating continued alignment with shareholder interests.
The sale of shares to cover tax obligations is a common practice and does not necessarily indicate any negative sentiment about the company's prospects.

Insider Trading Filed: 2026-02-25

Key Insights

David Foehr, the Senior VP of Finance and PAO at Ceribell, Inc., sold 1,350 shares of common stock over two days, likely to cover tax withholding obligations related to the vesting of restricted stock units.
The sales were made pursuant to a pre-arranged Rule 10b5-1 trading plan, indicating a planned and systematic approach to managing his equity position.
The reported transactions represent a relatively small portion (around 7%) of Foehr's total beneficial ownership in the company, suggesting this was a routine portfolio management activity rather than a significant shift in his investment strategy.

Insider Trading Filed: 2026-02-25

Key Insights

The reporting person, Joseph S. Manni, is the Chief Revenue Officer of Ceribell, Inc. and has disposed of 768 shares of common stock, likely to cover tax withholding obligations.
Manni still holds a significant number of 26,933 shares in the company, indicating his continued commitment as a senior executive.
The sale was executed at an average price of $19.79 per share, which suggests the stock is trading at a relatively high level.

Insider Trading Filed: 2026-02-25

Key Insights

The reporting person, Raymond Woo, who is the Chief Technology Officer of Ceribell, Inc., sold 705 shares of the company's common stock at a price of $19.79 per share.
The sale was to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) held by the reporting person.
Following the transaction, the reporting person still holds a direct ownership of 166,912 shares of Ceribell's common stock.

Insider Trading Filed: 2026-02-25

Key Insights

The reporting person, Scott Blumberg, who is the Chief Financial Officer of Ceribell, Inc., sold 808 shares of the company's common stock to cover tax withholding obligations related to the vesting of restricted stock units (RSUs).
Blumberg continues to beneficially own 118,334 shares of Ceribell's common stock, indicating he maintains a substantial stake in the company.
The transaction appears to be a routine share sale to cover tax liabilities, rather than a broader sell-off, which could be viewed positively by investors.

Annual Report Filed: 2026-02-24

Key Insights

Ceribell, Inc. (CBLL) filed its 10-K report for the fiscal year 2025, indicating the company's continued research and development efforts in the medical device industry.
The company reported revenue from its EEG portal and clarity subscriptions, as well as sales of EEG recorders and headbands, suggesting ongoing product development and commercialization.
Ceribell has outstanding restricted stock units and stock options, which could indicate potential dilution for shareholders in the future.

Current Report Filed: 2026-02-24

Key Insights

CeriBell, Inc. has reported its financial results for Q4 2025, indicating the company's performance during this period.
The filing does not provide any details on the company's financial performance or outlook, limiting the insights that can be gleaned.
Investors may need to wait for the full quarterly report or earnings call to get a more comprehensive understanding of CeriBell's recent performance and future prospects.

Insider Trading Filed: 2026-02-23

Key Insights

Insider Josef Parvizi has sold 16,714 shares of Ceribell, Inc. (CBLL) stock, representing a small portion of his overall holdings.
Parvizi continues to hold a significant indirect beneficial ownership in Ceribell, with over 2 million shares across various trusts.
The sale was executed pursuant to a pre-established 10b5-1 trading plan, suggesting it was part of a planned diversification strategy rather than a reaction to any specific company developments.

Insider Trading Filed: 2026-02-19

Key Insights

Insider Josef Parvizi sold a total of 8,286 shares of Ceribell, Inc. (CBLL) over two days, reducing his direct and indirect beneficial ownership to approximately 2 million shares.
The share sales were executed pursuant to a pre-planned Rule 10b5-1 trading plan, indicating they were not opportunistic in nature.
Parvizi maintains significant indirect ownership stakes in Ceribell through various trusts, suggesting he remains committed to the company's long-term success.

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Important Information